Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning.

@article{Glass2003MetastaticCO,
  title={Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning.},
  author={Tracy Ren{\'e}e Glass and Catherine M. Tangen and E. David Crawford and Ian M. Thompson},
  journal={The Journal of urology},
  year={2003},
  volume={169 1},
  pages={164-9}
}
PURPOSE While in patients with metastatic prostate cancer median survival is approximately 30 months when treated with hormonal therapy, there is substantial interpatient variation. To explain better the outcome in patients with advanced disease we developed a set of prognostic groups within a large-scale clinical trial. MATERIALS AND METHODS Southwest Oncology Group Study 8894 was a randomized prospective clinical trial that compared orchiectomy and flutamide to orchiectomy and placebo. Using… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 51 extracted citations

Similar Papers

Loading similar papers…